Patient Name : SASMITA GOHAIN Patient ID / Billing ID : 384713 / 426380

Age / Sex : 30 years / Female Specimen Collected by: Medibuddy

Ref. Doctor : SELF Sample Receiving
: 05 Feb, 2024, 09:11 a.m.
Client Name : Medibuddy Time
Sample ID : 7486254 Registration On : 05 Feb, 2024, 09:11 a.m.
Sample Type : EDTA WB Reported On : 05 Feb, 2024, 02:00 p.m.
Date of Birth : 04-12-1993

BIOCHEMISTRY

TEST DONE OBSERVED VALUE UNIT BIO. REF. INTERVAL METHOD

GLYCOSYLATED HEMOGLOBIN - HBA1C

HbA1c 4.66 % Below 6.0% - Normal Value

6.0% - 7.0% - Good Control
7.0% - 8.0% - Fair Control
8.0% - 10% - Unsatisfactory Control
■Above 10% - Poor Control

Method : High Performance Liquid Chromatography (HPLC)

AVERAGE BLOOD GLUCOSE 87.04 mg/dl

(ABG)

Technology CALCULATED

Method : Derived from HBA1c values

**END OF REPORT**

Scan to Validate

Page 1 of 24
 Patient Name : SASMITA GOHAIN Patient ID / Billing ID : 384713 / 426380
Age / Sex : 30 years / Female Specimen Collected by: Medibuddy
Ref. Doctor : SELF Sample Receiving
: 05 Feb, 2024, 09:11 a.m.
Client Name : Medibuddy Time
Sample ID : 7486255 Registration On : 05 Feb, 2024, 09:11 a.m.
Sample Type : Serum Reported On : 05 Feb, 2024, 02:49 p.m.
Date of Birth : 04-12-1993

BIOCHEMISTRY

TEST DONE OBSERVED VALUE UNIT BIO. REF. INTERVAL METHOD

LIPID PROFILE

Total Cholesterol 155.20 mg/dl Desirable : < 200 CHOD - PAP

Borderline High : 200 - 239
High : > 240

Triglycerides 120.10 mg/dl Normal : < 150 GK / GPO / POD

Borderline High : 151 - 199
High : ≥ 200

HDL Cholesterol 38.50 mg/dl < 35 Low CHOD - PAP

≥ 60 High

Non HDL Cholesterol 116.70 mg/dl Desirable : < 130 Calculated

Boderline high : 130 - 159
High : ≥ 160

LDL Cholesterol 92.68 mg/dL Desirable : <130 Calculated

Borderline High : 130-159
■High : ≥160

VLDL Cholesterol 24.02 mg/dl Below 30 Calculated

CHOL/HDL Ratio 4.03 Desirable/Low Risk : 3.3 - 4.4 Calculated

Borderline/Middle Risk : 4.5 - 7.1
Elevated/High Risk : 7.2 - 11.0

Cholesterol LDL/HDL Ratio 2.41 Desirable/Low Risk : 0.5 - 3.0

Borderline/Middle Risk : 3.1 - 6.0
Elevated/High Risk : >6.1

**END OF REPORT**

Scan to Validate

Page 2 of 24
 Patient Name : SASMITA GOHAIN Patient ID / Billing ID : 384713 / 426380
Age / Sex : 30 years / Female Specimen Collected by: Medibuddy
Ref. Doctor : SELF Sample Receiving
: 05 Feb, 2024, 09:11 a.m.
Client Name : Medibuddy Time
Sample ID : 7486255 Registration On : 05 Feb, 2024, 09:11 a.m.
Sample Type : Serum Reported On : 05 Feb, 2024, 02:49 p.m.
Date of Birth : 04-12-1993

Scan to Validate

Page 3 of 24
 Patient Name : SASMITA GOHAIN Patient ID / Billing ID : 384713 / 426380
Age / Sex : 30 years / Female Specimen Collected by: Medibuddy
Ref. Doctor : SELF Sample Receiving
: 05 Feb, 2024, 09:11 a.m.
Client Name : Medibuddy Time
Sample ID : 7486253 Registration On : 05 Feb, 2024, 09:11 a.m.
Sample Type : Fluoride Reported On : 05 Feb, 2024, 12:59 p.m.
Date of Birth : 04-12-1993

BIOCHEMISTRY

TEST DONE OBSERVED VALUE UNIT BIO. REF. INTERVAL METHOD

GLUCOSE - FASTING

Glucose Fasting 81.76 mg/dl Normal: 70 - 99 Hexokinase

(Plasma) Pre-Diabetic : 100 - 125
Diabetic : >126

Interpretation :
Fasting Blood Sugar more than 126 mg/dl on more than one occasion can indicate Diabetes Mellitus.

**END OF REPORT**

Scan to Validate

Page 4 of 24
 Patient Name : SASMITA GOHAIN Patient ID / Billing ID : 384713 / 426380
Age / Sex : 30 years / Female Specimen Collected by: Medibuddy
Ref. Doctor : SELF Sample Receiving
: 05 Feb, 2024, 09:11 a.m.
Client Name : Medibuddy Time
Sample ID : 7486255 Registration On : 05 Feb, 2024, 09:11 a.m.
Sample Type : Serum Reported On : 05 Feb, 2024, 02:49 p.m.
Date of Birth : 04-12-1993

BIOCHEMISTRY

TEST DONE OBSERVED VALUE UNIT BIO. REF. INTERVAL METHOD

LIVER FUNCTION TEST

Bilirubin Total 0.89 mg/dL 0.3 - 1.2 Diazo Salt Method

Bilirubin Direct 0.2 mg/dL 0.0 - 0.2 Diazo Salt Method

Bilirubin Indirect 0.69 mg/dL 0.3 - 1.0 Calculated

SGOT (AST) 24.40 U/L 13 - 30 IFCC

SGPT (ALT) 24.40 U/L 10 - 35 IFCC with P5P

Alkaline Phosphatase 83.80 U/L 33 - 98 IFCC / pNPP

Protein Total 7.90 g/dL 6.0 - 8.2 Biuret Method

Albumin 4.70 g/dL 4.0 - 5.0 Bromo-Cresol

Green

Globulin 3.20 g/dL 2.0 - 4.1 Calculated

A/G Ratio 1.47 1.0 - 2.1 Calculated

GGTP - Gamma GT 16.60 U/L 10 - 47 IFCC Reference

Method

Remark:

**END OF REPORT**

Scan to Validate

Page 5 of 24
 Patient Name : SASMITA GOHAIN Patient ID / Billing ID : 384713 / 426380
Age / Sex : 30 years / Female Specimen Collected by: Medibuddy
Ref. Doctor : SELF Sample Receiving
: 05 Feb, 2024, 09:11 a.m.
Client Name : Medibuddy Time
Sample ID : 7486255 Registration On : 05 Feb, 2024, 09:11 a.m.
Sample Type : Serum Reported On : 05 Feb, 2024, 02:50 p.m.
Date of Birth : 04-12-1993

BIOCHEMISTRY

TEST DONE OBSERVED VALUE UNIT BIO. REF. INTERVAL METHOD

KIDNEY BASIC SCREEN - KFT

Serum Urea 17.40 mg/dl 19 - 43 Glutamate

Dehydrogenase

BUN 8.13 mg/dl 8 - 22 Calculated

Serum Creatinine 0.34 mg/dl 0.40 - 0.70 ESPMT

Serum Uric acid 2.94 mg/dl 3.0 - 5.5 Uricase Peroxidse

BUN / Creatinine Ratio 23.91 12 - 20 Calculated

eGFR 170.89

Comments :

**END OF REPORT**

Scan to Validate

Page 6 of 24
 Patient Name : SASMITA GOHAIN Patient ID / Billing ID : 384713 / 426380
Age / Sex : 30 years / Female Specimen Collected by: Medibuddy
Ref. Doctor : SELF Sample Receiving
: 05 Feb, 2024, 09:11 a.m.
Client Name : Medibuddy Time
Sample ID : MB982569 Registration On : 05 Feb, 2024, 09:11 a.m.
Sample Type : Urine Reported On : 05 Feb, 2024, 01:17 p.m.
Date of Birth : 04-12-1993

CLINICAL PATHOLOGY

TEST DONE OBSERVED VALUE UNIT BIO. REF. INTERVAL METHOD

CUE - COMPLETE URINE ANALYSIS

Physical Examination

Colour Pale Yellow Pale yellow/Yellow Visual

Appearance Clear Clear Visual Examination

Specific Gravity 1.010 1.005-1.025 pKa Method

pH 7.0 5.0 - 8.0 Double Indicator

Chemical Examination

Protein Absent Absent Reflectance

Photometry /
Sulpho Salicylic
Acid Method

Sugar Absent Absent Oxidase

Peroxidase /
Benedict's Test

Ketones Absent Absent Nitroprusside

Reaction /
Rothera's Method

Bile Salt Absent Absent Hay's Test

Bile Pigment Absent Absent Fouchets method

Leucocyte Esterase Absent Absent Granulocyte

Esterases

Microscopic Examination (/hpf)

Pus Cell 2-3 Upto 5

Epithelial Cells 4-5 Upto 5 Microscopy

Scan to Validate

Page 7 of 24
 Patient Name : SASMITA GOHAIN Patient ID / Billing ID : 384713 / 426380
Age / Sex : 30 years / Female Specimen Collected by: Medibuddy
Ref. Doctor : SELF Sample Receiving
: 05 Feb, 2024, 09:11 a.m.
Client Name : Medibuddy Time
Sample ID : MB982569 Registration On : 05 Feb, 2024, 09:11 a.m.
Sample Type : Urine Reported On : 05 Feb, 2024, 01:17 p.m.
Date of Birth : 04-12-1993

Red Blood Cells Absent Absent Microscopy

Casts Absent Absent Microscopy

Crystals Absent Absent Microscopy

Amorphous Deposit Absent Absent Microscopy

Yeast Cells Absent Absent Microscopy

Bacteria Absent Absent Microscopy

Other findings Not Seen Not seen

**END OF REPORT**

Scan to Validate

Page 8 of 24
 Patient Name : SASMITA GOHAIN Patient ID / Billing ID : 384713 / 426380
Age / Sex : 30 years / Female Specimen Collected by: Medibuddy
Ref. Doctor : SELF Sample Receiving
: 05 Feb, 2024, 09:11 a.m.
Client Name : Medibuddy Time
Sample ID : 7486254 Registration On : 05 Feb, 2024, 09:11 a.m.
Sample Type : EDTA WB Reported On : 05 Feb, 2024, 12:51 p.m.
Date of Birth : 04-12-1993

HAEMATOLOGY

TEST DONE OBSERVED VALUE UNIT BIO. REF. INTERVAL METHOD

COMPLETE BLOOD COUNT - CBC

Haemoglobin 11.0 gm/dl 12.0 - 15.0 Cyanide Free

Method

Total WBC Count 8.52 10^3 / uL 4.0 - 10.0 Elec. Impedance &
Microscopy

RBC Count 5.6 10^6 / uL 3.82 - 4.8 Elec. Impedence

Haematocrit/Packed Cell 36.1 % 36 - 46 Calculated

Volume

MCV 64.46 fL 83 - 101 Derived from

impedance
variation

MCH 19.64 pg 27 - 32 Calculation

MCHC 30.47 gm/dl 31.5 - 34.5 Calculation

P-LCR 35.2 % 18.0 - 50.0

RWD-SD 37 fL 36 - 56 AT-Cell Counter

RDW-CV 19.5 % 11.5 - 14.5

MPV 9.3 fL 7.4 - 10.4 AT-Cell Counter

PDW 17.9 um^3 11.0 - 22.0

Platelet Count 104 10^3 / uL 150 - 410 Elec. Impedence /

Microscopy

DIFFERENTIAL COUNT

Neutrophils 53.1 % 40 - 80 Flow Cytometry /

Microscopy

Scan to Validate

Page 9 of 24
 Patient Name : SASMITA GOHAIN Patient ID / Billing ID : 384713 / 426380
Age / Sex : 30 years / Female Specimen Collected by: Medibuddy
Ref. Doctor : SELF Sample Receiving
: 05 Feb, 2024, 09:11 a.m.
Client Name : Medibuddy Time
Sample ID : 7486254 Registration On : 05 Feb, 2024, 09:11 a.m.
Sample Type : EDTA WB Reported On : 05 Feb, 2024, 12:51 p.m.
Date of Birth : 04-12-1993

Lymphocytes 37.6 % 20 - 40 Flow Cytometry /

Microscopy

Monocytes 6.7 % 2 - 10 Flow Cytometry /

Microscopy

Eosinophil 1.8 % 1-6 Flow Cytometry /

Microscopy

Basophils 0.8 % 0-1 Flow Cytometry /

Microscopy

Absolute Neutrophils Count 4.51 10^3/uL 1.5 - 8 Calculated

Absolute Lymphocyte Count 3.19 10^3/uL 1.5 - 8 Calculated

Absolute Eosinophil Count 0.15 10^3/uL 0.04 - 0.4 Calculated

Absolute Basophils Count 0.07 10^3/uL 0 - 0.2 Calculated

Absolute Monocyte Count 0.57 10^3/uL 0.2 - 1.0 Calculated

Note:

**END OF REPORT**

Scan to Validate

Page 10 of 24
 Patient Name : SASMITA GOHAIN Patient ID / Billing ID : 384713 / 426380
Age / Sex : 30 years / Female Specimen Collected by: Medibuddy
Ref. Doctor : SELF Sample Receiving
: 05 Feb, 2024, 09:11 a.m.
Client Name : Medibuddy Time
Sample ID : 7486255 Registration On : 05 Feb, 2024, 09:11 a.m.
Sample Type : Serum Reported On : 05 Feb, 2024, 02:38 p.m.
Date of Birth : 04-12-1993

BIOCHEMISTRY

TEST DONE OBSERVED VALUE UNIT BIO. REF. INTERVAL METHOD

ELECTROLYTES

Sodium 136.60 mmol/L 136 - 146 Indirect ISE

Potassium 4.80 mmol/L 3.5 - 5.1 Indirect ISE

Chloride 103 mmol/L 101 - 109 Indirect ISE

**END OF REPORT**

Scan to Validate

Page 11 of 24
 Patient Name : SASMITA GOHAIN Patient ID / Billing ID : 384713 / 426380
Age / Sex : 30 years / Female Specimen Collected by: Medibuddy
Ref. Doctor : SELF Sample Receiving
: 05 Feb, 2024, 09:11 a.m.
Client Name : Medibuddy Time
Sample ID : 7486255 Registration On : 05 Feb, 2024, 09:11 a.m.
Sample Type : Serum Reported On : 05 Feb, 2024, 01:57 p.m.
Date of Birth : 04-12-1993

BIOCHEMISTRY

TEST DONE OBSERVED VALUE UNIT BIO. REF. INTERVAL METHOD

LUTEINIZING HORMONE (LH)

LUTEINISING HORMONE 4.26 mIU/ml Male(23-70Yrs): 1.2-7.8 mIU/ml Method :Fully

(LH) Females: Automated
Bidirectionally
Normally Menstruating:
Interfaced Chemi
Follicular Phase : 2.58 - Luminescent
12.1 mIU/ml Immuno Assay
Mid-Cycle Peak : 27.3 -
96.9 mIU/ml
Luteal Phase : 0.833 - 15.5 mIU/ml
Post-Menopausal (w/o HRT) :
13.1-86.5 mIU/ml

**END OF REPORT**

Scan to Validate

Page 12 of 24
 Patient Name : SASMITA GOHAIN Patient ID / Billing ID : 384713 / 426380
Age / Sex : 30 years / Female Specimen Collected by: Medibuddy
Ref. Doctor : SELF Sample Receiving
: 05 Feb, 2024, 09:11 a.m.
Client Name : Medibuddy Time
Sample ID : 7486255 Registration On : 05 Feb, 2024, 09:11 a.m.
Sample Type : Serum Reported On : 05 Feb, 2024, 01:57 p.m.
Date of Birth : 04-12-1993

BIOCHEMISTRY

TEST DONE OBSERVED VALUE UNIT BIO. REF. INTERVAL METHOD

FOLLICLE STIMULATING HORMONE (FSH)

FOLLICLE STIMULATING 2.25 mIU/ml Normal Male: 1.55-9.74 mIU/mL Method :Fully
HORMONE (FSH) Normal Female Follicular phase: Automated
1.98-11.6 mIU/mL Bidirectionally
Normal Female Mid cycle peak: Interfaced Chemi
5.14-23.4 mIU/mL Luminescent
Immuno Assay
Normal Female Luteal phase:
1.38-9.58 mIU/mL
Post-menopausal female: 21.5-131
mIU/mL

**END OF REPORT**

Scan to Validate

Page 13 of 24
 Patient Name : SASMITA GOHAIN Patient ID / Billing ID : 384713 / 426380
Age / Sex : 30 years / Female Specimen Collected by: Medibuddy
Ref. Doctor : SELF Sample Receiving
: 05 Feb, 2024, 09:11 a.m.
Client Name : Medibuddy Time
Sample ID : 7486255 Registration On : 05 Feb, 2024, 09:11 a.m.
Sample Type : Serum Reported On : 05 Feb, 2024, 01:57 p.m.
Date of Birth : 04-12-1993

BIOCHEMISTRY

TEST DONE OBSERVED VALUE UNIT BIO. REF. INTERVAL METHOD

PROLACTIN

Prolactin 34.28 ng/mL Females : Method :Chemi

In reproductive age : 6.2 - 23.4 Luminescent
Postmenopausal : 4.2 - 18.4 Immuno Assay
Male : 4.0 - 18.4

Comments :

**END OF REPORT**

Scan to Validate

Page 14 of 24
 Patient Name : SASMITA GOHAIN Patient ID / Billing ID : 384713 / 426380
Age / Sex : 30 years / Female Specimen Collected by: Medibuddy
Ref. Doctor : SELF Sample Receiving
: 05 Feb, 2024, 09:11 a.m.
Client Name : Medibuddy Time
Sample ID : 7486255 Registration On : 05 Feb, 2024, 09:11 a.m.
Sample Type : Serum Reported On : 05 Feb, 2024, 01:56 p.m.
Date of Birth : 04-12-1993

IMMUNOLOGY

TEST DONE OBSERVED VALUE UNIT BIO. REF. INTERVAL METHOD

THYROID STIMULATING HORMONE (TSH)

THYROID STIMULATING 3.2898 µIU/mL 0.3 - 5.5 CLIA

HORMONE (TSH)
Method :
TSH - ENHANCED CHEMI LUMINESCENT IMMUNO ASSAY (ECLIA)

Pregnancy reference ranges for TSH

1st Trimester : 0.10 - 2.50
2nd Trimester : 0.20 - 3.00
3rd Trimester : 0.30 - 3.00
Reference range for < 18 years
TEST 1-3D 4 - 30 D 31 - 60 D 61 D - 12 M 1-5Y 6 - 10 Y 11 - 14 Y 15 - 18 Y

TSH 0.1-9.2 0.2-8.5 0.2-7.8 0.30-5.9 0.4-4.8 0.5-4.7 0.5-4.6 0.6-4.5

T3 41.7-272.1 48.2-272.1 54.7-272.1 76.8-272.1 89.2-246.7 87.2-218.1 86.6-199.8 85.3-188.8

T4 4.9-15.8 5-15.3 5.2-14.8 5.7-13.3 5.7-11.7 5.4-10.7 5.2-10 5.1-9.6

FT3 1.5-5.3 1.6-5.2 1.6-5.1 1.8-4.8 2-4.5 2.1-4.4 2.3-4.4 2.3-4.3

FT4 0.84-2.08 0.85-1.98 0.85-1.89 0.89-1.62 0.89-1.48 0.85-1.46 0.84-1.45 0.84-1.45

**END OF REPORT**

Scan to Validate

Page 15 of 24
 Patient Name : SASMITA GOHAIN Patient ID / Billing ID : 384713 / 426380
Age / Sex : 30 years / Female Specimen Collected by: Medibuddy
Ref. Doctor : SELF Sample Receiving
: 05 Feb, 2024, 09:11 a.m.
Client Name : Medibuddy Time
Sample ID : 7486255 Registration On : 05 Feb, 2024, 09:11 a.m.
Sample Type : Serum Reported On : 05 Feb, 2024, 01:56 p.m.
Date of Birth : 04-12-1993

Scan to Validate

Page 16 of 24
 Patient Name : SASMITA GOHAIN Patient ID / Billing ID : 384713 / 426380
Age / Sex : 30 years / Female Specimen Collected by: Medibuddy
Ref. Doctor : SELF Sample Receiving
: 05 Feb, 2024, 09:11 a.m.
Client Name : Medibuddy Time
Sample ID : 7486255 Registration On : 05 Feb, 2024, 09:11 a.m.
Sample Type : Serum Reported On : 05 Feb, 2024, 01:57 p.m.
Date of Birth : 04-12-1993

IMMUNOLOGY

TEST DONE OBSERVED VALUE UNIT BIO. REF. INTERVAL METHOD

VITAMIN B9 (FOLATE/FOLIC ACID)

FOLIC ACID 9.5 ng/ml Male: 4.5 - 32.2 CLIA

Female: 4.8 - 37.3
Comments :
Folic acid, also known as folate, are class of vitamin compounds, essential for nucleic acid and mitochondrial protein synthesis,
amino acid metabolism and aids in rapid cell division and growth. Deficiency seen in pregnancy, low dietary intake, macrocytic
and megaloblasic,
anaemia, drugs (phenytoin, disease, celiac disease, malabsorption syndromes, ileo-jejunal surgeries. Deficiency is also
associated with neural tube defects in developing embryo. Low serum folate levels reflect the first stage of negative folate
balance. Low RBC folate reflects second stage of negative folate balance. Low RBC folate reflects second stage of negative
folate ballance and more closely correlates with tissue levels and megaloblasic anaemia.

**END OF REPORT**

Scan to Validate

Page 17 of 24
 Patient Name : SASMITA GOHAIN Patient ID / Billing ID : 384713 / 426380
Age / Sex : 30 years / Female Specimen Collected by: Medibuddy
Ref. Doctor : SELF Sample Receiving
: 05 Feb, 2024, 09:11 a.m.
Client Name : Medibuddy Time
Sample ID : 7486255 Registration On : 05 Feb, 2024, 09:11 a.m.
Sample Type : Serum Reported On : 05 Feb, 2024, 01:56 p.m.
Date of Birth : 04-12-1993

IMMUNOLOGY

TEST DONE OBSERVED VALUE UNIT BIO. REF. INTERVAL METHOD

VITAMIN D 25 (OH)

Vitamin D Total-25 Hydroxy 15.5 ng/mL Deficiency < 20 CLIA

(Serum) Insufficiency : 20 - 30
Sufficiency : 30 - 100
Toxicity > 150
Interpretation:
Vitamin D deficiency can result from inadequate exposure to the sun, inadequate alimentary intake, decreased absorption,
abnormal metabolism, or vitamin D resistance. Recently, many chronic diseases such as cancer, high blood pressure,
osteoporosis, and several autoimmune diseases have been linked to vitamin D deficiency. Vitamin D toxicity is known but very
rare.
Remark :
Vitamin D is essential for the formation and maintenance of strong, healthy bones.

**END OF REPORT**

Scan to Validate

Page 18 of 24
 Patient Name : SASMITA GOHAIN Patient ID / Billing ID : 384713 / 426380
Age / Sex : 30 years / Female Specimen Collected by: Medibuddy
Ref. Doctor : SELF Sample Receiving
: 05 Feb, 2024, 09:11 a.m.
Client Name : Medibuddy Time
Sample ID : 7486255 Registration On : 05 Feb, 2024, 09:11 a.m.
Sample Type : Serum Reported On : 05 Feb, 2024, 03:04 p.m.
Date of Birth : 04-12-1993

BIOCHEMISTRY

TEST DONE OBSERVED VALUE UNIT BIO. REF. INTERVAL METHOD

SERUM TRANSFERRIN

Serum Transferrin 237.1 mg/dl 206 - 381 Immunoturbidimetry

**END OF REPORT**

Scan to Validate

Page 19 of 24
 Patient Name : SASMITA GOHAIN Patient ID / Billing ID : 384713 / 426380
Age / Sex : 30 years / Female Specimen Collected by: Medibuddy
Ref. Doctor : SELF Sample Receiving
: 05 Feb, 2024, 09:11 a.m.
Client Name : Medibuddy Time
Sample ID : 7486255 Registration On : 05 Feb, 2024, 09:11 a.m.
Sample Type : Serum Reported On : 05 Feb, 2024, 02:48 p.m.
Date of Birth : 04-12-1993

PATHOLOGY

TEST DONE OBSERVED VALUE UNIT BIO. REF. INTERVAL METHOD

IRON PROFILE

Iron 45.60 ug/dL 37.00 - 170.00 Serum, Ferene

UIBC 332.90 ug/dl 110 - 370

Total Iron Binding Capacity 378.50 ug/dL 250- 450 Serum, Ferene

Transferrin Saturation 12.05 % 13-45 Calculated

Comments
Iron is an essential trace mineral element which forms an important component of hemoglobin,
metallocompounds and Vitamin A. Deficiency of iron, leads to microcytic hypochromic anemia. The toxic
effects of iron are deposition of iron in various organs of the body and hemochromatosis.
Total Iron Binding capacity (TIBC) is a direct measure of the protein Transferrin which transports iron from
the gut to storage sites in the bone marrow. In iron deficiency anemia, serum iron is reduced and TIBC
increases.
Transferrin Saturation occurs in Idiopathic hemochromatosis and Transfusional hemosiderosis where no
unsaturated iron binding capacity is available for iron mobilization. Similar condition is seen in congenital
deficiency of Transferrin.

**END OF REPORT**

Scan to Validate

Page 20 of 24
 Patient Name : SASMITA GOHAIN Patient ID / Billing ID : 384713 / 426380
Age / Sex : 30 years / Female Specimen Collected by: Medibuddy
Ref. Doctor : SELF Sample Receiving
: 05 Feb, 2024, 09:11 a.m.
Client Name : Medibuddy Time
Sample ID : 7486255 Registration On : 05 Feb, 2024, 09:11 a.m.
Sample Type : Serum Reported On : 05 Feb, 2024, 03:03 p.m.
Date of Birth : 04-12-1993

BIOCHEMISTRY

TEST DONE OBSERVED VALUE UNIT BIO. REF. INTERVAL METHOD

CALCIUM - SERUM

Calcium Total (Serum) 9.78 mg/dl 8.8 - 10.6 Colorimetric -

Arsenazo Method

Method :Colorimetric - Arsenazo Method

**END OF REPORT**

Scan to Validate

Page 21 of 24
 Patient Name : SASMITA GOHAIN Patient ID / Billing ID : 384713 / 426380
Age / Sex : 30 years / Female Specimen Collected by: Medibuddy
Ref. Doctor : SELF Sample Receiving
: 05 Feb, 2024, 09:11 a.m.
Client Name : Medibuddy Time
Sample ID : 7486255 Registration On : 05 Feb, 2024, 09:11 a.m.
Sample Type : Serum Reported On : 05 Feb, 2024, 02:38 p.m.
Date of Birth : 04-12-1993

BIOCHEMISTRY

TEST DONE OBSERVED VALUE UNIT BIO. REF. INTERVAL METHOD

PHOSPHORUS

Phosphorus 3.68 mg/dL 2.5 - 4.5 Photometric UV

Method

**END OF REPORT**

Scan to Validate

Page 22 of 24
 Patient Name : SASMITA GOHAIN Patient ID / Billing ID : 384713 / 426380
Age / Sex : 30 years / Female Specimen Collected by: Medibuddy
Ref. Doctor : SELF Sample Receiving
: 05 Feb, 2024, 09:11 a.m.
Client Name : Medibuddy Time
Sample ID : 7486255 Registration On : 05 Feb, 2024, 09:11 a.m.
Sample Type : Serum Reported On : 05 Feb, 2024, 01:56 p.m.
Date of Birth : 04-12-1993

IMMUNOLOGY

TEST DONE OBSERVED VALUE UNIT BIO. REF. INTERVAL METHOD

VITAMIN - B12

VITAMIN B-12 154 pg/mL Normal :187-883pg/mL CLIA

Clinical significance :
• Vitamin B 12 deficiency frequently causes macrocytic anemia, glossitis, peripheral neuropathy, weakness, hyperreflexia,
ataxia, loss of proprioception, poor coordination and affective behavioral changes.
• Many patients have the neurologic defects without macrocytic anemia. Serum methylmalonic acid (MMA) and homocysteine
levels are also elevated in Vit B 12 deficiency states.
• Vitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources, such as
meat, eggs and milk.
• It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation and in the formation of myelin sheath.
Vitamin-B12 is used to find out neurological abnormalities and impaired DNA synthesis associated with macrocytic anemias.
• For diagnostic purpose, results should always be assessed in conjunction with the patients medical history, clinical
examination and other findings.

Please correlate with clinical conditions.

Limitations:
• The evaluation of macrocytic anemia requires measurement of both vitamin B12 and Folate levels: ideally they should be
measured simultaneously.
• Specimen collection soon after blood transfusion can falsely increase Vit B12 levels.
• Patient taking Vit B12 supplementation may have misleading results.
• A normal serum concentration of B12 does not rule out tissue deficiency of Vit B12. The most sensitive test at the cellular
level is the assay for MMA.
• If Clinical symptoms suggest deficiency, measurement of MMA and Homocysteine should be considered, even if serum B12
concentrations are normal.

**END OF REPORT**

Scan to Validate

Page 23 of 24
 Patient Name : SASMITA GOHAIN Patient ID / Billing ID : 384713 / 426380
Age / Sex : 30 years / Female Specimen Collected by: Medibuddy
Ref. Doctor : SELF Sample Receiving
: 05 Feb, 2024, 09:11 a.m.
Client Name : Medibuddy Time
Sample ID : 7486255 Registration On : 05 Feb, 2024, 09:11 a.m.
Sample Type : Serum Reported On : 05 Feb, 2024, 01:56 p.m.
Date of Birth : 04-12-1993

Scan to Validate

Page 24 of 24